Login / Signup
Cost-effectiveness analysis of COVID-19 booster vaccination with BNT162b2 in Japan.
Mitsuhiro Nagano
Kazumasa Kamei
Hiroyuki Matsuda
Chihiro Takahashi
Jingyan Yang
Koji Wada
Naohiro Yonemoto
Published in:
Expert review of vaccines (2024)
Booster vaccination with the COVID-19 vaccine BNT162b2 is a dominant strategy and beneficial to public health in Japan.
Keyphrases
</>
coronavirus disease
public health
sars cov
respiratory syndrome coronavirus